Atlas Trials

Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease

Clinical trial NCT00053976 · COMPLETED

Trial details

NCT number
NCT00053976
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2001-01-01
Primary completion
2003-11-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.